Valiant Laboratories LtdPharmaceuticalsINE0JWS01017Consolidated₹124.71+2.12 (+1.73%)Jun-26
Valuation
Market Cap₹669.46 Cr
TTM PE41.78x
Forward PE31.77x
PEG-0.06
Book Value₹57.24
P/B2.15x
TTM EPS₹2.95
Fwd EPS₹3.88
TTM Revenue₹305.93 Cr
TTM PAT₹16.00 Cr
TTM EBITDA₹30.54 Cr
TTM EBIT₹24.22 Cr
Last Qtr PAT₹21.10 Cr
Last Qtr EBITDA₹29.27 Cr
Last Qtr EBIT₹26.41 Cr
Profitability
ROE5.15%
ROCE8.35%
TTM NPM5.23%
TTM EBITDA %9.98%
Curr OPM18.17%
Last OPM1.91%
Curr NPM
Last NPM
Curr EPS₹3.89
Last EPS₹0.32
Balance sheet
Equity₹54.31 Cr
Reserve₹256.57 Cr
Total Debt₹45.42 Cr
D/E0.15x
Interest %5.07%
Curr Interest₹1.07 Cr
Price / range
Close₹123.26
vs 52W High
vs 52W Low
MA50
MA200
Returns
1D+0.42%
1W-2.17%
1M+36.59%
3M+80.79%
6M+146.90%
1Y+42.61%
2Y+1.07%
3Y
5Y
Diwali+79.31%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue73.42+43.9%65.3054.7445.9951.01217.04
Other Income0.850.770.610.850.672.89
Total Income74.27+43.7%66.0855.3546.8351.68219.94
Interest0.080.020.040.140.070.26
Expenditure-61.55-25.0%-61.34-55.24-46.58-49.23-212.39
PBDT000000
EBITDA12.50+429.7%4.500.260.062.367.17
Depreciation-0.55-0.52-0.72-0.51-0.51-2.26
EBIT11.95+545.9%3.98-0.46-0.451.854.91
PBT12.73+419.6%4.730.110.262.457.55
Tax-3.25-1.20-0.08-0.09-0.63-2
Equity54.3154.310043.4543.45
OPM17.147.160.200.564.743.43
Net Profit9.48+420.9%3.530.030.171.825.55
NPM12.765.340.060.363.522.52
EPS1.75+316.7%0.650.010.030.421.02

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 3 years
MetricFY 25-26FY 24-25FY 23-24
Revenue217.04+62.7%133.36-26.7%182.05
Other Income2.895.439.68
Total Income219.94+58.5%138.79-27.6%191.73
Expenditure-212.39-51.4%-140.24+27.1%-192.49
Interest-0.26-0.18-0.08
PBDT000
EBITDA7.17+253.2%-4.68+44.4%-8.41
Depreciation-2.26-2.02-1.95
EBIT4.91+173.3%-6.70+35.3%-10.36
PBT7.55+620.7%-1.45-93.3%-0.75
Tax-2-0.701.09
Equity43.4543.450
OPM (%)3.43-1.040.00
Net Profit5.55+358.1%-2.15-732.4%0.34
NPM (%)2.52-1.550.00
EPS (Rs)1.020-100.0%0.14
CEPS1.1000.14

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue115.29+146.2%91.9852.4646.2046.82237.47
Other Income0.860.170.630.870.662.32
Total Income116.15+144.6%92.1553.0947.0747.48239.79
Interest1.071.0100.140.071.90
Expenditure-89.95-99.8%-91.11-56.08-46.79-45.03-239.02
PBDT000000
EBITDA29.27+1124.7%4.81-3.620.082.396.39
Depreciation-2.86-2.930-0.53-0.53-6.04
EBIT26.41+1319.9%1.88-3.62-0.451.860.35
PBT26.19+969.0%1.0500.282.450.77
Tax-5.090.71-4.07-0.08-0.63-4.04
Equity54.3154.310043.4554.31
OPM22.551.140.000.595.160.32
Net Profit21.10+1059.3%1.76-7.060.201.82-3.27
NPM18.171.91-13.290.423.83-1.36
EPS3.89+826.2%0.3200.040.420

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 3 years
MetricFY 25-26FY 24-25FY 23-24
Revenue237.47+78.0%133.38-26.7%182.06
Other Income2.325.439.68
Total Income239.79+72.7%138.82-27.6%191.74
Expenditure-239.02-70.3%-140.33+27.1%-192.51
Interest-1.90-0.18-0.08
PBDT000
EBITDA6.39+236.5%-4.68+44.3%-8.40
Depreciation-6.04-2.09-1.97
EBIT0.35+105.2%-6.77+34.7%-10.37
PBT0.77+151.0%-1.51-96.1%-0.77
Tax-4.04-0.691.09
Equity54.3143.450
OPM (%)0.32-1.09-0.40
Net Profit-3.27-48.6%-2.20-787.5%0.32
NPM (%)-1.36-1.590.17
EPS (Rs)00-100.0%0.13
CEPS000.13

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

0

No dividend history.

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers